Does AXITINIB Cause Hyperglycaemia? 31 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Hyperglycaemia have been filed in association with AXITINIB (INLYTA). This represents 0.2% of all adverse event reports for AXITINIB.
31
Reports of Hyperglycaemia with AXITINIB
0.2%
of all AXITINIB reports
2
Deaths
15
Hospitalizations
How Dangerous Is Hyperglycaemia From AXITINIB?
Of the 31 reports, 2 (6.5%) resulted in death, 15 (48.4%) required hospitalization, and 4 (12.9%) were considered life-threatening.
Is Hyperglycaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AXITINIB. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does AXITINIB Cause?
Death (2,222)
Diarrhoea (2,187)
Fatigue (1,816)
Neoplasm progression (1,315)
Hypertension (1,146)
Off label use (1,075)
Nausea (955)
Decreased appetite (920)
Dysphonia (871)
Disease progression (768)
What Other Drugs Cause Hyperglycaemia?
INSULIN GLARGINE (1,903)
METFORMIN (1,626)
ALPELISIB (1,575)
DEXAMETHASONE (1,169)
PREDNISONE (1,135)
INSULIN LISPRO (743)
PREDNISOLONE (705)
INSULIN ASPART (646)
INSULIN HUMAN (620)
METHYLPREDNISOLONE (604)
Which AXITINIB Alternatives Have Lower Hyperglycaemia Risk?
AXITINIB vs AZACITIDINE
AXITINIB vs AZATHIOPRINE
AXITINIB vs AZD-1222
AXITINIB vs AZELAIC ACID
AXITINIB vs AZELASTINE